Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis

Nature Biotechnology

Volumn 16, Issue 4, 1998, Pages 359-363

  Piatek, Amy S ^e   Tyagi, Sanjay ^a   Pol, Arno C ^b   Telenti, Amalio ^c   Miller, Lincoln P ^d   Kramer, Fred Russell ^a   Alland, David ^e  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Genetic testing; Molecular probes; Pathogen screening; Rifampin

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BASE PAIRING; DNA SEQUENCE; GENE MUTATION; MOLECULAR PROBE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PLANT PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; RIFAMPIN;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0031969531     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0498-359     Document Type: Article

References (28)

1. Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T.R., Neuhausen, S. et al. 1996. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 2:1179-1183.
2. Beutler, E. 1992. Gaucher disease: new molecular approaches to diagnosis and treatment. Science 256:794-799.
3. Larder, B.A. and Kemp, S.D. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246:1155-1158.
4. Omata, M., Ehata, T., Yokosuka, O., Hosoda, K., and Ohto, M. 1990. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N. Engl. J. Med. 322:178-183.
5. Tompkins, L.S. 1992. The use of molecular methods in infectious diseases. N. Engl. J. Med. 327:1290-1297.
6. Lipshutz, R.J., Morris, D., Chee, M., Hubbell, E., Kozal, M.J., Shah, N. et al. 1995. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19:442-447.
7. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86:2766-2770.
8. White, M.B., Carvalho, M., Derse, D., O'Brien, S.J., and Dean, M. 1992. Detecting single base substitutions as heteroduplex polymorphisms. Genomics 12:301-306.
9. Nash, K.A., Gaytan, A., and Inderlied, C.B. 1997. Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J. Infect. Dis. 176:533-536.
10. Tyagi, S. and Kramer, F.R. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nature Biotechnology 14:303-308.
11. Tyagi, S., Bratu, D.P., and Kramer, F.R. 1998. Multicolor molecular beacons for allele discrimination. Nature Biotechnology 16:49-53.
12. Centers for Disease Control. 1993. Estimates of future global tuberculosis morbidity and mortality. Morb. Mortal. Wkly. Rep. 42:961-964.
13. Fischl, M.A., Uttamchandani, R.B., Daikos, G.L., Poblete, R.B., Moreno, J.N., Reyes, R.R. et al. 1992. An outbreak of tuberculosis caused by multi-drug-resistant tubercle bacilli among patients with HIV infection. Ann. Intern. Med. 117:177-183.
14. Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L., and Horsburgh, E. R. Jr. 1993. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med. 328:527-532.
15. Heifets, L.B. 1986. Rapid automated methods (BACTEC system) in clinical mycobacteriology. Semin. Respir. Infect. 1:242-249.
16. Pablos-Mendez, A., Sterling, T.R., and Frieden, T.R. 1996. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276:1223-1228.
17. Turett, G.S., Telzak, E.E., Torian, L.V., Blum, S., Alland, D., Weisfuse, I. et al. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21:1238-1244.
18. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J. et al. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
19. Mitchison, D. and Nunn, A. 1986. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. American Review of Respiratory Diseases 133:423-430.
20. Musser, J.M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
21. Williams, D.L., Waguespack, C., Eisenach, K., Crawford, J.T., Portaels, F., Salfinger, M. et al. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
22. De Beenhouwer, H., Lhiang, Z., Hannes, G. et al. 1994. Rapid detection of rifampin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber. Lung Dis. 76:425-430.
23. van Soolingen, D., Hermans, P.W.M., de Haas, P.E.W., Soll, E.R., and van Embden, J.D.A. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
24. Alland, D., Kalkut, G.E., Moss, A.R., McAdam, R.A., Hahn, J.A., Bosworth, W. et al. 1994. Transmission of tuberculosis in New York City, an analysis by DNA fingerprinting and Conventional Epidemologic Methods. N. Engl. J. Med. 330:1710-1716.
25. Telenti, A., Honore, N., Bernasconi, C., March, J., Ortega, A., Heym, B. et al. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Micro. 35:719-723.
26. Kent, P.R. and Kubica, G.P. 1985. Public health mycobacteriology: A guide for the level III laboratory. Atlanta: Department of Health and Human Services.
27. Chaulet, P., Boulahbal, F., and Grosset, J. 1995. Surveillance of drug resistance for tuberculosis control: Why and how? Tuber. Lung Dis. 76:487-492.
28. Kox, L.F.F., Van Leeuwen, J., Knijper, S., Jansen, H.M., and Kolk, A.H.J. 1995. PCR assay based on DNA coding for 16S rRNA for detection and identification of Mycobacteria in clinical samples. J. Clin. Microbiol. 35:3225-3233.